141 related articles for article (PubMed ID: 33663063)
1. Image-based diagnosis of residual or recurrent nasopharyngeal carcinoma may be a phantom tumor phenomenon.
Lee CC; Lee JC; Huang WY; Juan CJ; Jen YM; Lin LF
Medicine (Baltimore); 2021 Feb; 100(8):e24555. PubMed ID: 33663063
[TBL] [Abstract][Full Text] [Related]
2. Significance of boost dose for T4 nasopharyngeal carcinoma with residual primary lesion after intensity-modulated radiotherapy.
Fei Z; Xu T; Qiu X; Li M; Chen T; Li L; Huang C; Chen C
J Cancer Res Clin Oncol; 2021 Jul; 147(7):2047-2055. PubMed ID: 33392660
[TBL] [Abstract][Full Text] [Related]
3. Detecting plasma Epstein-Barr virus DNA to diagnose postradiation nasopharyngeal skull base lesions in nasopharyngeal carcinoma patients: a prospective study.
Liang FY; Sun W; Han P; Lu X; Lian YN; Huang XM
Chin J Cancer; 2012 Mar; 31(3):142-9. PubMed ID: 22237037
[TBL] [Abstract][Full Text] [Related]
4. The use of MR imaging to detect residual versus recurrent nasopharyngeal carcinoma following treatment with radiation therapy.
Lin GW; Wang LX; Ji M; Qian HZ
Eur J Radiol; 2013 Dec; 82(12):2240-6. PubMed ID: 24103355
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous remission of residual post-therapy plasma Epstein-Barr virus DNA and its prognostic implication in nasopharyngeal carcinoma: A large-scale, big-data intelligence platform-based analysis.
Zhang Y; Tang LL; Li YQ; Liu X; Liu Q; Ma J
Int J Cancer; 2019 May; 144(9):2313-2319. PubMed ID: 30485420
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of gross tumor regression and plasma Epstein Barr Virus DNA levels at the end of intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma.
Liang SB; Zhang N; Chen DM; Yang XL; Chen BH; Zhao H; Lu RL; Chen Y; Fu LW
Radiother Oncol; 2019 Mar; 132():223-229. PubMed ID: 30366725
[TBL] [Abstract][Full Text] [Related]
7. [Clinical study on endoscopic surgery for soft tissue necrosis of cranial base after radiotherapy for nasopharyngeal carcinoma].
Zhang H; Gao KL; Xie ZH; Zhang JY; Fan RH; Wang FJ; Xie SM; Jiang WH
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Jan; 56(1):26-32. PubMed ID: 33472299
[No Abstract] [Full Text] [Related]
8. Utility of magnetic resonance imaging in determining treatment response and local recurrence in nasopharyngeal carcinoma treated curatively.
Meng K; Tey J; Ho FCH; Asim H; Cheo T
BMC Cancer; 2020 Mar; 20(1):193. PubMed ID: 32143592
[TBL] [Abstract][Full Text] [Related]
9. Hopkins criteria for residual disease assessment after definitive radiotherapy in nasopharyngeal carcinoma.
Liu Y; Long W; Wang G; Yang Y; Liu B; Fan W
Cancer Med; 2020 Feb; 9(4):1328-1334. PubMed ID: 31875356
[TBL] [Abstract][Full Text] [Related]
10. Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults: preliminary results from the prospective, multicenter study NPC-2003-GPOH/DCOG.
Buehrlen M; Zwaan CM; Granzen B; Lassay L; Deutz P; Vorwerk P; Staatz G; Gademann G; Christiansen H; Oldenburger F; Tamm M; Mertens R
Cancer; 2012 Oct; 118(19):4892-900. PubMed ID: 22359313
[TBL] [Abstract][Full Text] [Related]
11. Intravoxel incoherent motion MRI in differentiation between recurrent carcinoma and postchemoradiation fibrosis of the skull base in patients with nasopharyngeal carcinoma.
Mao J; Shen J; Yang Q; Yu T; Duan X; Zhong J; Phuyal P; Liang B
J Magn Reson Imaging; 2016 Dec; 44(6):1556-1564. PubMed ID: 27227674
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal brain structural alterations in patients with nasopharyngeal carcinoma early after radiotherapy.
Guo Z; Han L; Yang Y; He H; Li J; Chen H; Song T; Qiu Y; Lv X
Neuroimage Clin; 2018; 19():252-259. PubMed ID: 30035019
[TBL] [Abstract][Full Text] [Related]
13. [Value of FDG PET-CT associated with pathology in diagnosing residual tumor in patients with nasopharyngeal carcinoma after radiotherapy].
Chen L; Zhang N; Wang Y; Xian W; Hu W; Wei G
Zhonghua Zhong Liu Za Zhi; 2015 Mar; 37(3):213-5. PubMed ID: 25975792
[TBL] [Abstract][Full Text] [Related]
14. Complementary roles of MRI and endoscopic examination in the early detection of nasopharyngeal carcinoma.
King AD; Woo JKS; Ai QY; Chan JSM; Lam WKJ; Tse IOL; Bhatia KS; Zee BCY; Hui EP; Ma BBY; Chiu RWK; van Hasselt AC; Chan ATC; Lo YMD; Chan KCA
Ann Oncol; 2019 Jun; 30(6):977-982. PubMed ID: 30912815
[TBL] [Abstract][Full Text] [Related]
15. [Value of the endoscopic diagnosis on the lesions of the skull base in postradiotherapeutic patients with nasopharyngeal carcinoma].
Lyu JY; Liang FY; Han P; Huang XM
Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):384-388. PubMed ID: 28535658
[No Abstract] [Full Text] [Related]
16. Prognostic value of plasma Epstein-Barr virus DNA level during posttreatment follow-up in the patients with nasopharyngeal carcinoma having undergone intensity-modulated radiotherapy.
Li WF; Zhang Y; Huang XB; Du XJ; Tang LL; Chen L; Peng H; Guo R; Sun Y; Ma J
Chin J Cancer; 2017 Nov; 36(1):87. PubMed ID: 29116021
[TBL] [Abstract][Full Text] [Related]
17. The value of detailed MR imaging report of primary tumor and lymph nodes on prognostic nomograms for nasopharyngeal carcinoma after intensity-modulated radiotherapy.
Wan Y; Tian L; Zhang G; Xin H; Li H; Dong A; Liang Y; Jing B; Zhou J; Cui C; Chen M; Sun Y; Xie C; Liu L; Shao Y
Radiother Oncol; 2019 Feb; 131():35-44. PubMed ID: 30773185
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and prognostic value of pre-retreatment plasma epstein-barr virus DNA in locoregional recurrent nasopharyngeal carcinoma.
Liu MZ; Fang SG; Huang W; Wang HY; Tian YM; Huang RD; Sun Z; Zhao C; Lu TX; Huang Y; Han F
Cancer Med; 2019 Aug; 8(10):4633-4643. PubMed ID: 31268626
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of diffusion-weighted magnetic resonance imaging for local and skull base recurrence of nasopharyngeal carcinoma after radiotherapy.
Wang C; Liu L; Lai S; Su D; Liu Y; Jin G; Zhu X; Luo N
Medicine (Baltimore); 2018 Aug; 97(34):e11929. PubMed ID: 30142809
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of the post-radiotherapy
Jeong Y; Jung IH; Kim JS; Chang SK; Lee SW
Br J Radiol; 2019 Oct; 92(1102):20180045. PubMed ID: 30102562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
